Demand for high tibial osteotomy plates is expected to increase as a result of recent advancements in osteotomy plates which drives High Tibial Osteotomy (HTO) Plates Market. The overall accuracy of currently recommended surgical procedures employing high tibial osteotomy (HTO) plates is low, indicating the growing development of high accuracy modern HTO surgeries. The use of 3D printing technology in the production of HTO plates leads in great precision and improved results. For instance, in 2021, the Centre for Therapeutic Innovation (CTI) at the University of Bath in the United Kingdom introduced the world’s first 3D printed high tibial osteotomy device and method, which was approved for trials in the United Kingdom. It’s a tailored early knee osteoarthritis treatment created by engineers at the University of Bath’s Centre for Therapeutic Innovation (CTI) that makes personalised medical-grade titanium-alloy plates using state-of-the-art 3D metal printing technology. The TOKA treatment enhances the operating method for realigning a patient’s knee, making it more pleasant, stable, and weight-bearing than conventional generic plates. More advancements like these are expected to occur in the future, boosting demand for high tibial osteotomy plates. As a result of the aforementioned factors, the market is expected to increase significantly during the forecast period. igh tibial osteotomy procedure is widely used for the treatment of knee arthrosis. In addition, HTO uses a variety of procedures, including closed wedge, open wedge, and progressive callus distraction. The market rise because to an increasing geriatric population that is prone to different bone-related illnesses. During the projected period, an increase in the incidence and prevalence of arthritis among individuals is expected to drive market growth. High tibial osteotomy is performed to reshape the tibia and also relieve pressure of osteoarthritis has damaged one side of knee. Patients with musculoskeletal diseases such knee osteoarthritis and Blount’s disease may benefit from high tibial osteotomy surgery.
The incidence of osteoarthritis and osteoporosis is higher in North America. HTO plates are frequently utilised in the treatment of osteoporosis patients. As a result, the rising frequency of this condition in North American countries is likely to promote market growth for high tibial osteotomy plates throughout the forecast period. Other reasons that are projected to boost the high tibial osteotomy plates market in this region are the low cost of high tibial osteotomy and improvements in health care infrastructure.
Olympus Corporation announced the acquisition of GROUPE FH ORTHO in November 2020. The acquisition of GROUPE FH ORTHO strengthened the sales channels by expanding the distribution of both Olympus’ orthopaedic products and particular products in Japan through GROUPE FH ORTHO’s existing distribution networks.
Smith & Nephew bought Integra LifeSciences Holdings Corporation’s extremities orthopaedics business in September 2020. The acquisition bolstered the company’s operations by expanding the product pipeline and providing a targeted sales channel.
To know more @
The global High Tibial Osteotomy (HTO) Plates market accounted for US$ 303.54 million in 2020 and is estimated to be US$ 468.39 million by 2030 and is anticipated to register a CAGR of 4.5%. The Global High Tibial Osteotomy (HTO) Plates Market is segmented by Type, application, and Region.
By Type, Global High Tibial Osteotomy (HTO) Plates Market is segmented into Metals and Polymers.
By Application, Global High Tibial Osteotomy (HTO) Plates Market is segmented into Hospitals and Clinics.
By Region, Global High Tibial Osteotomy (HTO) Plates Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America has higher incidence of osteoporosis and osteoarthritis cases.
The key operators of the Global High Tibial Osteotomy (HTO) Plates Market are DePuy Synthes (Johnson & Johnson), Arthrex, Inc., aap Implantate AG, Stryker Corporation, Braun Melsungen AG, Wright Medical Group N.V., Acumed, LLC, TriMed, Inc., Tornier, Inc., and Medical & Optical Instruments Australia Pty Ltd.